Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04163900
Title Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer (NuTide:121)
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors NuCana plc

ampulla of Vater adenocarcinoma

biliary tract cancer


Cisplatin + NUC-1031

Cisplatin + Gemcitabine

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN

No variant requirements are available.